CAM
MEDP icon

Congress Asset Management’s Medpace MEDP Stock Holding History

Congress Asset Management’s Portfolio MEDP Stock Details MEDP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$37.7M Buy
60,479
+2,000
+3% +$1.17M 0.24% 110
2026
Q2 		$31M Sell
58,479
-1,708
-3% -$788K 0.19% 129
2026
Q1 		$28.9M Sell
60,187
-191
-0.3% -$97.8K 0.21% 125
2025
Q4 		$33.9M Sell
60,378
-4,317
-7% -$2.45M 0.24% 117
2025
Q3 		$33.3M Buy
64,695
+7,190
+13% +$3.14M 0.22% 118
2025
Q2 		$18M Buy
57,505
+2,517
+5% +$756K 0.12% 145
2025
Q1 		$16.8M Buy
54,988
+1,292
+2% +$435K 0.13% 147
2024
Q4 		$17.8M Buy
53,696
+6,878
+15% +$2.33M 0.12% 143
2024
Q3 		$15.6M Sell
46,818
-2,519
-5% -$957K 0.11% 149
2024
Q2 		$20.3M Sell
49,337
-106,069
-68% -$42M 0.15% 127
2024
Q1 		$62.8M Buy
155,406
+2,012
+1% +$707K 0.45% 82
2023
Q4 		$47M Buy
153,394
+5,819
+4% +$1.57M 0.37% 87
2023
Q3 		$35.7M Buy
147,575
+12,317
+9% +$3.15M 0.32% 86
2023
Q2 		$32.5M Buy
135,258
+22,803
+20% +$4.74M 0.28% 89
2023
Q1 		$21.1M Buy
112,455
+1,658
+1% +$343K 0.2% 104
2022
Q4 		$23.5M Sell
110,797
-2,306
-2% -$461K 0.24% 89
2022
Q3 		$17.8M Buy
113,103
+7,444
+7% +$1.19M 0.19% 96
2022
Q2 		$15.8M Sell
105,659
-617
-0.6% -$89.3K 0.15% 106
2022
Q1 		$17.4M Buy
106,276
+27,087
+34% +$4.47M 0.15% 98
2021
Q4 		$17.2M Buy
79,189
+5,904
+8% +$1.24M 0.13% 100
2021
Q3 		$13.9M Buy
73,285
+1,620
+2% +$295K 0.11% 110
2021
Q2 		$12.7M Buy
71,665
+1,046
+1% +$181K 0.11% 110
2021
Q1 		$11.6M Buy
70,619
+4,796
+7% +$734K 0.1% 110
2020
Q4 		$9.16M Buy
65,823
+3,391
+5% +$427K 0.09% 134
2020
Q3 		$6.98M Sell
62,432
-948
-1% -$110K 0.08% 144
2020
Q2 		$5.9M Buy
63,380
+8,942
+16% +$761K 0.07% 142
2020
Q1 		$4M Buy
54,438
+11,740
+27% +$1.02M 0.06% 164
2019
Q4 		$3.59M Buy
42,698
+2,715
+7% +$210K 0.04% 204
2019
Q3 		$3.36M Buy
+39,983
New +$3.02M 0.04% 225

Other funds holding MEDP

AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
ACM
Argent Capital Management St Louis, Missouri $3.14B AUM 31.36% 1-Year Est. Return
MCM
Monument Capital Management Alexandria, Virginia $480M AUM 43.68% 1-Year Est. Return
AIM
Ausbil Investment Management Sydney, Australia $199M AUM 17.66% 1-Year Est. Return
CI
CX Institutional Auburn, Indiana $3.69B AUM 15.82% 1-Year Est. Return
GI
GAMMA Investing Foster City, California $2.96B AUM 34.38% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
RA
Riversedge Advisors Wilmington, Delaware $813M AUM 18.09% 1-Year Est. Return
TAM
Titleist Asset Management San Antonio, Texas $1.55B AUM 13.34% 1-Year Est. Return
VAG
VisionPoint Advisory Group Dallas, Texas $636M AUM 21.4% 1-Year Est. Return

Congress Asset Management's MEDP Position: Q3 2026 in Review

Congress Asset Management increased its Medpace (MEDP) stake by 3.4% in Q3 2026, buying an estimated $1.17M and bringing the position to 60,479 shares worth $37.7M. The position accounts for 0.24% of the portfolio, ranked #110.

Congress Asset Management first reported a position in MEDP in Q3 2019 and has held it in 29 quarters since. The position peaked at $62.8M in Q1 2024. 22 funds tracked by Wall St. Rank hold MEDP as of Q3 2026.

  • Congress Asset Management held 60,479 shares of Medpace worth $37.7M as of Q3 2026.
  • Congress Asset Management bought 2,000 Medpace shares in Q3 2026, an estimated $1.17M.
  • Medpace made up 0.24% of Congress Asset Management's portfolio in Q3 2026, its #110 holding.
  • Congress Asset Management first reported a position in Medpace in Q3 2019 and has held it in 29 quarters since.
  • Congress Asset Management's Medpace position peaked at $62.8M in Q1 2024.
  • 22 funds tracked by Wall St. Rank held Medpace as of Q3 2026.

Based on Congress Asset Management's 13F filing for Q3 2026, filed 6 Oct 2026.